Health Services Research
Latest posts by Health Services Research (see all)
- The Effect of Medicaid Physician Fee Increases on Health Care Access, Utilization, and… - Apr. 17, 2017
- Validity and Reliability of Administrative Coded Data for the Identification of… - Apr. 11, 2017
- A Two-Step Method to Identify Positive Deviant Physician Organizations of Accountable Care… - Apr. 06, 2017
- Disparities in Potentially Preventable Hospitalizations: Near-National Estimates for Hispanics - Apr. 05, 2017
Background Assessing the real-world comparative effectiveness of common interventions is challenged by unmeasured confounding. Objective To determine whether the mortality benefit shown for drug-eluting stents (DES) over bare metal stents (BMS) in observational studies persists after controls for/tests for confounding. Data Sources/Study Setting Retrospective observational study involving 38,019 patients, 65 years or older admitted for an index percutaneous coronary intervention receiving DES or BMS in Pennsylvania in 2004–2005 followed up for death through 3 years. Study Design Analysis was at the patient level.